(Q34233431)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Lysophosphatidic acid and ovarian cancer: a paradigm for tumorogenesis and patient management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

J R Erickson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Hasegawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

X Fang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Eder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Mao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

T Furui

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

A Morris

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

Prostaglandins and Other Lipid Mediators

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

63-81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

Screening for ovarian cancer

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

CA 125: the past and the future

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

The CA 125 tumour-associated antigen: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Toward an optimal algorithm for ovarian cancer screening with longitudinal tumor markers.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Adjuvant therapy in stage I and stage II epithelial ovarian cancer. Results of two prospective randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Markedly elevated levels of vascular endothelial growth factor in malignant ascites

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Malignant effusions contain lysophosphatidic acid (LPA)-like activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophospholipids activate ovarian and breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidic acid: a bioactive phospholipid with growth factor-like properties

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidic acid: a novel phospholipid with hormone- and growth factor-like activities

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Sphingosine-1-phosphate modulates growth and adhesion of ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Effect of lysophospholipids on signaling in the human Jurkat T cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Identification of lysophospholipid receptors in human platelets: the relation of two agonists, lysophosphatidic acid and sphingosine 1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Endothelial cell mitogenesis induced by LPA: inhibition by thrombospondin-1 and thrombospondin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Motility and invasion are differentially modulated by Rho family GTPases

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Mechanism of endothelium-dependent vasorelaxation evoked by lysophosphatidylcholine.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Sphingosine 1-phosphate-induced cell proliferation, survival, and related signaling events mediated by G protein-coupled receptors Edg3 and Edg5

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

1 reference

7 January 2021

The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Phorbol 12-myristate 13-acetate stimulates lysophosphatidic acid secretion from ovarian and cervical cancer cells but not from breast or leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Possible role of phospholipase D in cellular differentiation and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

The PLD superfamily: insights into catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Production of lysophosphatidic acid by lysophospholipase D in incubated plasma of spontaneously hypertensive rats and Wistar Kyoto rats

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Production of lysophosphatidic acids by lysophospholipase D in human follicular fluids of In vitro fertilization patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Acyltransferases and transacylases involved in fatty acid remodeling of phospholipids and metabolism of bioactive lipids in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

A specific human lysophospholipase: cDNA cloning, tissue distribution and kinetic characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Cloning, expression, and catalytic mechanism of murine lysophospholipase I.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Sequence, expression in Escherichia coli, and characterization of lysophospholipase II.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Human type 2 phosphatidic acid phosphohydrolases. Substrate specificity of the type 2a, 2b, and 2c enzymes and cell surface activity of the 2a isoform

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Elevated levels and altered fatty acid composition of plasma lysophosphatidylcholine(lysoPC) in ovarian cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

The significance of urokinase- type plasminogen activator, its inhibitors, and its receptor in ascites of patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Involvement of small GTPases Rho and Rac in the invasion of rat ascites hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Rho GTPases and signaling networks

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

A macrophage activating factor is present and active in the ascitic fluid of patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Disruption of epithelial cell-matrix interactions induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Control of adhesion-dependent cell survival by focal adhesion kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Inositol trisphosphate mediates cloned muscarinic receptor-activated conductances in transfected mouse fibroblast A9 L cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Intracellular calcium release mediated by two muscarinic receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidic acid possesses dual action in cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Inhibition by cAMP of Ras-dependent activation of Raf.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Inhibition of tumor invasion and metastasis by a novel lysophosphatidic acid (cyclic LPA)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Structure--activity relationships of lysophosphatidic acid: conformationally restricted backbone mimetics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Structure/activity relationships in lysophosphatidic acid: the 2-hydroxyl moiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

Characterization of a receptor subtype-selective lysophosphatidic acid mimetic

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2801%2900100-9

7 January 2021

10.1016/S0090-6980(01)00100-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11324708%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference